Related Experiment Videos
Central blocks with levobupivacaina in children
1Anesthesia and Intensive Care Department, Ospedali Riuniti of Bergamo, Bergamo, Italy. pabloingelmo@libero.it
Minerva Anestesiologica
|May 12, 2005
Summary
Levobupivacaine offers a safer alternative to bupivacaine for paediatric regional anesthesia, particularly in infants and neonates. This local anesthetic demonstrates a lower incidence of motor blockade and potentially higher toxicity tolerance.
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
- Regional Anesthesia
Background:
- Regional anesthesia is common in pediatric patients, utilizing local anesthetics for pain management.
- Bupivacaine is frequently used for its long-acting properties, but carries risks of systemic toxicity affecting the heart and brain.
- Levobupivacaine is an alternative local anesthetic used in various pediatric regional anesthesia techniques.
Purpose of the Study:
- To evaluate the safety and efficacy of levobupivacaine compared to bupivacaine in pediatric regional anesthesia.
- To identify clinical scenarios where levobupivacaine may offer improved safety profiles.
Main Methods:
- Review of clinical use of levobupivacaine and bupivacaine in pediatric patients.
- Comparison of toxicity profiles and incidence of adverse events, including motor blockade.
- Analysis of safety in specific procedures like caudal blocks and in vulnerable populations such as neonates.
Main Results:
- Levobupivacaine shows comparable clinical effects to bupivacaine.
- Levobupivacaine results in a lower incidence of residual motor blockade.
- Patients receiving levobupivacaine may tolerate higher doses before toxicity manifestation, especially during accidental intravenous infusion.
Conclusions:
- Levobupivacaine appears to be a safer option than bupivacaine in pediatric regional anesthesia.
- Consideration of levobupivacaine is particularly warranted for prolonged infusions, use in neonates/small infants, and caudal blocks.
- Minimizing risks in pediatric regional anesthesia involves reducing anesthetic dose, preventing accidental injections, and selecting agents with lower toxicity potential.